Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

IMRET spotlight on Vapourtec

Posted on: 01 Sep 16
IMRET spotlight on Vapourtec

Flow chemistry specialists Vapourtec will be playing a prominent role at the forthcoming 2016 IMRET (International Conferences on MicroREaction Technology) conference in Beijing (Sept 11-14).

As well as an exhibition stand (booth 10) showcasing the E-Series easy-MedChem system and UV-150 photochemical reactor, Vapourtec’s continuous process technology will be highlighted in two speaker presentations.

On day 1 Michael Oelgemoeller of James Cook University in Australia will present his work entitled “Flow photochemistry made easy in the advanced Vapourtec UV-150 flow photoreactor”.

In addition Pierre-Baptiste Flandrin of Bath University UK will present a poster entitled “Synthesis and control of spin crossover compound [Fe(Htrz)2(trz)](BF4) nanoscale particles with tubular flow reactors”. 

Vapourtec MD Duncan Guthrie commented: “Vapourtec is linking up at IMRET with Tegent Scientific Ltd, our exclusive distribution partner for China and Hong Kong. Jack Ding from Tegent will be joining me in Beijing to help demonstrate the capabilities of the easy-MedChem system and UV-150 photochemical reactor.

“We are delighted that our flow chemistry technology, already cited in over 200 publications, will also be in the spotlight as part of the two presentations.  

“The work of Pierre-Baptiste Flandrin involves using our R-Series system and comparing the particle size distribution achievable in batch with that achievable in a range of tubular reactors manufactured by Vapourtec.  Tubular reactors used vary in volume from 30 mL to 140 mL,” added Duncan.

This year's IMRET is co-hosted by Tsinghua University and Dalian Institute of Chemical Physics, Chinese Academy of Sciences.

For more details visit and

For more information:

Editor's Details

rob wilkinson

Last updated on: 01/09/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.